Literature DB >> 25964506

Delayed linkage to care in one-third of HIV-positive individuals in the Netherlands.

M G van Veen1, S C M Trienekens2, T Heijman3, H M Gotz4, S Zaheri5, G Ladbury6, J de Wit7, J S A Fennema3, F de Wolf5, M A B van der Sande8.   

Abstract

OBJECTIVES: To determine time to linkage to HIV care following diagnosis and to identify risk factors for delayed linkage.
METHODS: Patients newly diagnosed with HIV at sexually transmitted infections (STI) clinics in the Netherlands were followed until linkage to care. Data were collected at the time of diagnosis and at first consultation in care, including demographics, behavioural information, CD4+ counts and HIV viral load (VL) measurements. Delayed linkage to care was defined as >4 weeks between HIV diagnosis and first consultation.
RESULTS: 310 participants were included; the majority (90%) being men who have sex with men (MSM). For 259 participants (84%), a date of first consultation in care was known; median time to linkage was 9 days (range 0-435). Overall, 95 (31%) of the participants were not linked within 4 weeks of diagnosis; among them, 44 were linked late, and 51 were not linked at all by the end of study follow-up. Being young (<25 years), having non-Western ethnicity or lacking health insurance were independently associated with delayed linkage to care as well as being referred to care indirectly. Baseline CD4+ count, VL, perceived social support and stigma at diagnosis were not associated with delayed linkage. Risk behaviour and CD4+ counts declined between diagnosis and linkage to care.
CONCLUSIONS: Although most newly diagnosed patients with HIV were linked to care within 4 weeks, delay was observed for one-third, with over half of them not yet linked at the end of follow-up. Vulnerable subpopulations (young, uninsured, ethnic minority) were at risk for delayed linkage. Testing those at risk is not sufficient, timely linkage to care needs to be better assured as well. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  EPIDEMIOLOGY (GENERAL); HIV TESTING; PREVENTION

Mesh:

Year:  2015        PMID: 25964506     DOI: 10.1136/sextrans-2014-051980

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  7 in total

1.  Factors associated with presenting late or with advanced HIV disease in the Netherlands, 1996-2014: results from a national observational cohort.

Authors:  Eline L M Op de Coul; Ard van Sighem; Kees Brinkman; Birgit H van Benthem; Marchina E van der Ende; Suzanne Geerlings; Peter Reiss
Journal:  BMJ Open       Date:  2016-01-04       Impact factor: 2.692

2.  Motives and barriers to safer sex and regular STI testing among MSM soon after HIV diagnosis.

Authors:  Titia Heijman; Freke Zuure; Ineke Stolte; Udi Davidovich
Journal:  BMC Infect Dis       Date:  2017-03-07       Impact factor: 3.090

3.  Integrating hepatitis B, hepatitis C and HIV screening into tuberculosis entry screening for migrants in the Netherlands, 2013 to 2015.

Authors:  Janneke P Bil; Peter Ag Schrooders; Maria Prins; Peter M Kouw; Judith He Klomp; Maarten Scholing; Lutje Phm Huijbregts; Gerard Jb Sonder; Toos Chfm Waegemaekers; Henry Jc de Vries; Wieneke Meijer; Freke R Zuure; Alma Tostmann
Journal:  Euro Surveill       Date:  2018-03

4.  Effective linkage from point of HIV testing to care and treatment in Tanga region, Tanzania.

Authors:  David Elias Kayabu; James Samwel Ngocho; Blandina Theophil Mmbaga
Journal:  PLoS One       Date:  2018-08-16       Impact factor: 3.240

5.  Understanding Reasons for HIV Late Diagnosis: A Qualitative Study Among HIV-Positive Individuals in Amsterdam, The Netherlands.

Authors:  Maarten Bedert; Udi Davidovich; Godelieve de Bree; Ward van Bilsen; Ard van Sighem; Wim Zuilhof; Kees Brinkman; Marc van der Valk; John de Wit
Journal:  AIDS Behav       Date:  2021-03-31

6.  Impact of Male Circumcision among heterosexual HIV cases: comparisons between three low HIV prevalence countries.

Authors:  Daniel Chemtob; Eline Op de Coul; Ard van Sighem; Zohar Mor; Françoise Cazein; Caroline Semaille
Journal:  Isr J Health Policy Res       Date:  2015-08-04

Review 7.  Linkage to HIV care following diagnosis in the WHO European Region: A systematic review and meta-analysis, 2006-2017.

Authors:  Sara Croxford; Zheng Yin; Fiona Burns; Andrew Copas; Katy Town; Sarika Desai; Andrew Skingsley; Valerie Delpech
Journal:  PLoS One       Date:  2018-02-16       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.